研究：業績

【2022】Editorial（英文）

• Ohishi M.
• Can pulse transit time-estimated blood pressure become a savior for blood pressure research?
  Hypertens Res 2022; 45: 1070-1071.
• Ohishi M.
• Sacubitril/valsartan -A new weapon for fighting the hypertension paradox.
  Hypertens Res 2022; 45: 915-916.
• Ikeda Y.
• Measurement of nutritional status as frailty severity is indispensable to treat patients with chronic limb-threatening ischemia.
  J Atheroscler Thromb 2022 Feb 1;29(2):150-151.
• Yuasa T, Ohishi M.
• Additional benefits of evaluating short-term blood pressure variability: recommendation of twice-daily home blood pressure measurement.
  Hypertens Res 2022 Jan;45(1):175-177.
• Tokushige A, Ohishi M.
• Pathophysiology of the exaggerated blood pressure response to exercise.
  Hypertens Res 2022; 45: 2028-2029.